The Centers for Disease Control and Prevention on Thursday recommended that adults ages 60 and above receive a single dose of RSV vaccines from Pfizer and GSK after consulting their doctors.
"These vaccines provide an opportunity to help protect older adults against severe RSV illness at a time when multiple respiratory infections are likely to circulate," the CDC said in a statement.
The virus is a common respiratory infection that usually causes mild, cold-like symptoms, but more severe cases in older adults and children.
Each year, RSV kills 6,000 to 10,000 seniors and a few hundred children younger than 5, according to CDC data.
But the panel raised concerns about the lack of efficacy data on subgroups of the elderly population at the highest risk of severe RSV.
Persons:
Rochelle Walensky, Michael Melgar
Organizations:
Disease Control, Pfizer, GSK, CDC, U.S . Food, Drug Administration, Spokespeople
Locations:
U.S